· Op-Ed/Commentary
COVID-19GovernmentIntellectual PropertyUnited States Taxpayer-Funded Drug Research Should Require Open-Source Sharing by Big PharmaDean Baker / LA PROGRESSIVE / July 27, 2020
· Op-Ed/Commentary
Affordable Care ActCOVID-19DisabilityHealth and Social ProgramsUnited StatesWorkers Disability and Employment in the Time of Coronavirus: The 30th Anniversary of the Americans With Disabilities ActHayley Brown / July 24, 2020
· Op-Ed/Commentary
COVID-19Economic JusticeHealth and Social ProgramsUnited StatesWorkers Early Care and Education: Necessary Infrastructure for Economic RecoveryEileen Appelbaum / INTERECONOMICS / July 23, 2020
· Op-Ed/Commentary
COVID-19United StatesWorkers Labor Market Transitions of Young People During the PandemicHye Jin RhoJulie Yixia CaiShawn Fremstad / July 21, 2020
· Op-Ed/Commentary
COVID-19 New York Times Can’t Find Out About Chinese Coronavirus VaccinesDean Baker / July 21, 2020
· Op-Ed/Commentary
COVID-19Health and Social ProgramsWorkers Multiple Jobholders: Who Are They and How Are They Impacted by the Pandemic?Hye Jin RhoShawn Fremstad / July 17, 2020
· Op-Ed/Commentary
COVID-19Economic Growth Was Government Assistance Necessary to Help U.S. Industries Survive the Coronavirus Pandemic?Dean Baker / CQ RESEARCHER / July 17, 2020
· Article
COVID-19GovernmentHealth and Social ProgramsIntellectual PropertyUnited States The Smart Rx to Slash Drug Costs: Two Obvious Steps to Take FirstDean Baker / NEW YORK DAILY NEWS / July 15, 2020
· Op-Ed/Commentary
COVID-19Economic Crisis and RecoveryIntellectual Property New York Times Is Badly Confused About Economics of Coronavirus VaccineDean Baker / July 15, 2020
· Op-Ed/Commentary
COVID-19Economic Crisis and RecoveryInequalityIntellectual Property Is it Impossible to Envision a World Without Patent Monopolies?Dean Baker / July 06, 2020
